Alliance Pharma PLC
28 July 2004
28 July 2004
ALLIANCE PHARMA PLC
('Alliance' or 'the Company')
NOTIFICATION OF OPTIONS GRANTED
Alliance Pharma plc, today announced that it has granted share options to two
company directors. Details are as follows:
Director Name Madeleine Scott
Date of Grant 27 July 2004
Number of options granted 335,000
Period/date on which exercisable On or after 1 May 2007 and before 1 May
2014
Total amount paid (if any for grant of the option) None
Exercise price 15.5p
Description of shares 1p Ordinary
Total no. of options held following this notification 335,500
Director Name Anthony Booley
Date of Grant 27 July 2004
Number of options granted 342,500
Period/date on which exercisable On or after 1 May 2007 and before 1 May
2014
Total amount paid (if any for grant of the option) None
Exercise price 15.5p
Description of shares 1p Ordinary
Total no. of options held following this notification 342,500
- ends -
For further information:
Alliance Pharma plc
John Dawson, CEO
01249 466966
Beattie Financial
James Chandler/John Moriarty
020 7398 3300
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.